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Three kinds of derivatives of the M1 factor of virginiamycin have been synthesised: esters with long chain
fatty acids, oximes with modiﬁed polar amino acids and bis-derivatives with both the ester and oxime
function. The study of the surface tension time dependence of M1 and its derivatives has shown that it
is necessary to enhance simultaneously the hydrophobicity and the hydrophilicity of M1 to render M1
surface-active. A structure/function relationship study of the surface-active bis-derivatives has shown
that enhancing the hydrophobicity of the molecule led to slower adsorption kinetics, higher stability of
the monolayers formed and a better capacity to penetrate a membrane model. The repulsive electrostatic




greater molecular area at the interface and lower penetration into a membrane model.





























Virginiamycin is a streptograminantibiotic producedby fermen-
ation using Streptomyces virginiae. It is composed of two classes of
tructurally unrelated molecules, the M (M1, M2 and M3) and S fac-
ors (S1, S2, S3, S4 and S5) which are respectively, polyunsaturated
acrolactones and cyclic hexadepsipeptides [1]. The M1 factor is
he major constituent and represents approximately 65wt.% of
he antibiotic. Virginiamycin inhibits the biosynthesis of proteins.
he two types of factors used separately are bacteriostatic against
ram positive bacteria, while their mixture is bactericidal due to a
ynergistic effect. Although the ribosomes of Gram negative bacte-
ia appear as sensitive to the antibiotic as those of Gram positive
trains, Gram negative bacteria are resistant to virginiamycin. This
ould be due to an impermeability of the outermembranes of these
acteria [2].
The therapeutic applications of virginiamycin have been limited
ut it has been successfully used commercially as a growth promot-
ng agent in animal husbandry for many years. However with the
rowing problem of antibiotic resistance, interest in this antibiotic
as been renewed and new derivatives of virginiamycin have been
eveloped, such as dalfopristine. Synercid, a 70/30 combination
f dalfopristin/quinupristin has been used against Staphylococ-
us aureus and Staphylococcus epidermidis resistant to methycillin
nd Enterococcus faecium resistant to vancomycin, which are Gram
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positive bacteria particularly important in nosocomial infections
[3–6].
The aim of this work was to produce and characterize surface-
active virginiamycin M1 derivatives. The planar formula of M1
represented in Fig. 1(a) shows the presence of polar functions
(hydroxyl, ketone, lactone, lactame etc.) and of more hydrophobic
groups (methyls, isopropyl etc.) but no clear separation between
a hydrophilic and a hydrophobic zone can be seen. To render M1
surface-active it is necessary to enhance its amphiphilicity. As a
ﬁrst step, it was decided to evaluate the impact on M1’s sur-
face properties of increasing separately either its hydrophobicity
or hydrophilicity or of increasing both characters simultaneously.
Three types of derivatives have thus been synthesised: hydrophobic
esters with fatty acids of increasing chain length (octanoic, dode-
canoic, tetradecanoic acids), hydrophilic oximes with polar amino
acids (serine, lysine, aspartic acid) and bis-derivatives with both
an ester and an oxime function. The impact of these modiﬁcations
on M1’s capacity to decrease the surface tension of water has been
studied. In the second part of this work a more complete study of
the surface-active derivatives was undertaken. The inﬂuence of the
derivatives structure on their propertieswas investigated by study-
ing the surface tension timedependence of their solutions and their
compression isotherms. Finally, the ability of these compounds to
penetrate into a membrane model has been evaluated.Different studies have shown that surface activitymay be linked
to many biological properties (antibacterial, fungicidal, antiviral
etc.) of biosurfactants. Exampleswould be the surfactin lipopeptide
of Bacillus subtilis [7] and rhamnolipids produced by Pseudomonas
aeruginosa [8]. New surface-active derivatives of M1 may increase





























Sig. 1. Planar formula of M1 (a) and general planar formula of M1’s derivatives: (
R =CH2OH),M1AOALys (R= (CH2)4NH2) and M1AOAAsp (R=CH2COOH); (d) the b
=4),M1C12AOALys (R= (CH2)4NH2 and n=8),M1C12AOAAsp (R=CH2COOHand n=
he bioavailability of the antibiotic and may help it to penetrate the
utermembraneof resistantGramnegativebacteria and reach their
ensitive ribosomes. The association of biological and surfactant




Virginiamycin M fraction was donated by Phibro Animal Health
.A. (Rixensart, Belgium). It had been produced on an industrial
cale by fermentation using S. virginiae. After acidiﬁcation of the
roth, the antibiotic was extracted with methyl isobutyl ketone
henprecipitatedbyn-hexane. Finally, theM fractionwas separated
y successive crystallisation steps in methanol. Highly puriﬁed
1 (HPLC-UV(214nm) purity >99%) was obtained via the method
eveloped by Nott et al. [9]. The technique involved elimination of
he impurities remaining from theM fraction byﬁltration on a silica
el cake followed by reversed-phase ﬂash chromatography.
The following chemicals were purchased from: Alexis (Switzer-
and): TBTU (C11H16N5OBF4) 98%; Acros Organics (USA): N,N-
iisopropylethylamine (C8H19N) 98%;Aldrich (Germany): aminooxy
cetic acid (AOA) ((H2NOCH2CO2H)2.HCl) 98%; dimethylsulfox-
de (C2H6OS) anhydrous 99.9%; dodecanoic anhydride (C24H46O3)
8%; octanoic anhydride (C16H30O3) 99%; piperidine (C5H11N)
9%; pyridine (C5H5N) anhydrous 99.8%; tetradecanoic anhy-
ride (C28H54O3) 95%; Merck (Germany): Acetic acid (C2H4O2)
or analysis 96%; 4-dimethylamino-pyridine (C7H10N2) for syn-
hesis; Neosystem (France): N-hydrobenzotriazole (C6H5N3O.H2O);
charlau (Spain): Acetonitrile (CH3CN) HPLC grade; chloro-esters M1C8 (n=5),M1C12 (n=9) and M1C14 (n=11); (c) the oximes M1AOASer
ivatives M1C8AOALys (R= (CH2)4NH2 and n=4),M1C8AOAAsp (R=CH2COOH and
C14AOALys (R= (CH2)4NH2 and n=10) andM1C14AOAAsp (R=CH2COOHand n=10)
form (CHCl3) multisolvent, stabilised with ca. 0.5% ethanol;
dichloromethane (CH2Cl2) multisolvent stabilised with ca. 50ppm
amylene; isopropanol (C3H8O) multisolvent; methanol (CH3OH)
multisolvent; N-methylpyrrolidone (C5H9NO) for peptide syn-
thesis; sodium acetate (C2H3O2Na.3H2O); Sds(France): triﬂuo-
roacetic acid (CF3CO2H) for synthesis; Sigma (Germany): dl-
-dipalmitoylphosphatidylcholine (C40H80NO8P) 99%; VWR (Bel-
gium): ethanol (C2H5OH) absolute for analysis.
The water used for measurement of the surface properties was
milliQ and prepared with a Millipore Synthesis A10 apparatus.
The glassware was cleaned with a sulfochromic mixture and
rinsed with distilled and milliQ water.
2.2. Synthesis and puriﬁcation of virginiamycin M1 derivatives
2.2.1. M1 esters with fatty acids (octanoic, dodecanoic and
tetradecanoic acid)
- Commercial chloroform contains ethanol as the stabilising
agent. To avoid side reactions, the ethanol was eliminated by
liquid–liquid extraction. One volume of the commercial chloro-
form was extracted ﬁve times with 1/2 volume of milliQ water.
Anhydrousmagnesiumsulphatewas then added to theCHCl3 free
of ethanol obtained. Themixturewas stirred at room temperature
overnight. The magnesium sulphate was eliminated by ﬁltration.
- Synthesis: M1 +2eq. fatty acid anhydrides and pyridine +0.5 eq.
4-(dimethylamino)-pyridine, in chloroform free of stabiliserwere
stirred magnetically at room temperature, for 1h. The synthesis
was stopped by adding one volume of cold (4 ◦C) methanol.
- Pre-puriﬁcation: this was done via reversed-phase ﬂash chro-
matography (octadecylsilicagel and elution with a mixture of
methanol water in a ratio depending upon the length of the fatty



























It is important to note that blanks where only 40l of DMSO70 K. Nott et al. / Colloids and Surfac
acid linked) followedbypuriﬁcationby reversed-phaseHPLC (C18
column and isocratic elution using a mixture of acetonitrile and
water with 0.1% triﬂuoroacetic acid in a ratio depending of the
length of the chain).
In the rest of the text, the abbreviations M1C8, M1C12 and M1C14
will be used to refer to, respectively, the octanoate, dodecanoate
and tetradecanoate of M1. The general planar formula of these
esters is shown in Fig. 1(b).
.2.2. M1 oximes with polar amino acids (serine (Ser), lysine
Lys), aspartic acid (Asp))
The oximes of M1 with serine, lysine and aspartic acid were syn-
thesised and puriﬁed as previously described [10]. Brieﬂy, the
introduction of the aminooxy moiety on the amino acids by Fmoc
solid phase peptide synthesis using AOA was followed by reac-
tion between the modiﬁed amino acid and M1 and puriﬁcation
via reversed-phase HPLC.
In the rest of the text, the abbreviationsM1AOASer,M1AOALys and
M1AOAAsp will be used to refer, respectively to the oxime of M1
with serine, lysine and aspartic acid. The general planar formula
of these oximes is shown in Fig. 1(c).
Each of the oximes synthesised exists under two isomeric forms
and they will be referred to as isomer 1(I1) and isomer 2 (I2)
throughout the text. Both isomers of the oximes were puriﬁed
and studied separately.
.2.3. M1 bis-derivatives
M1’s esters were obtained as described above (Section 2.2.1)
The oximes of the esterswere synthesised using the samemethod
as for M1’s oximes (Section 2.2.2) and puriﬁed by reversed-phase
HPLC (C18 column and elution with a gradient of acetonitrile and
water with 0.1% triﬂuoroacetic acid in a ratio depending of the
length of the chain).
In the rest of the text, the abbreviations M1C8AOALys,
M1C8AOAAsp, M1C12AOALys, M1C12AOAAsp, M1C14AOALys and
M1C14AOAAsp will be used to refer, respectively to the bis-
derivatives of M1 with lysine or aspartic acid with a fatty chain
of 8, 12 or 14 carbon atoms. The general planar formula of these
bis-derivatives is shown in Fig. 1(d).
Each of the bis-derivatives synthesised exists under two isomeric
forms and they will be referred to as isomer 1 (I1) and isomer
2 (I2) throughout the text. For the bis-derivatives with a chain
length of 8 carbon atoms mixtures of both isomers were used. For
the longer chain length derivatives (C12 and C14), both isomers
were separated.
HPLC-UV (214nm) purity levels of a minimum of 98% were
chieved for both M1 and its derivatives. The identity of all the
erivatives was conﬁrmed after synthesis and puriﬁcation by a
ombination of spectral techniques (IR, mass and NMR).
.3. Surface tension measurements
The surface tension timedependence of aqueous solutions ofM1
nd its derivatives was measured with the automated drop volume
ensiometer TVT 1 (Lauda, Germany). The design and procedures
or use of this apparatus have been fully described by Miller et al.
11]. In the dynamic mode used, the volume of the drops formed
y the apparatus is continuously increasing and each successive
rop is formed more and more slowly. This allows measurement
f the surface tension as a function of the quantity of surfactant
aving had time to reach the surface of the drop. The volume of the
yringe was 2.5mL and the radius of its capillary was 1.055mm. All
easurements were performed at 25±0.5 ◦C. Each measurement
as repeated twice.iointerfaces 69 (2009) 268–275
M1 and its derivatives were solubilised either in milliQ water or
in an acetate buffer 25mM at pH 5. The concentrations of the solu-
tions were determined by HPLC-UV (214nm) using a calibration
curve.
2.4. Compression isotherms
The surface pressure measurements were done on a KSV
Langmuir ﬁlm balance (KSV instrument, Helsinki, Finland). The
apparatus consists of a rectangular Teﬂon trough (364×75×5mm)
with a central well (37×37×70mm), two mobile barriers, a
Wilhelmy plate (19.62×10mm), a temperature probe and a ther-
mostatisation system linked to a water bath Julabo F12-MV (Julabo,
Labortechnik GmbH, Seelbach, Germany). Between each analysis,
the trough, the barriers, the temperature probe and the Wilhelmy
plate were cleaned with pure isopropanol and rinsed thoroughly
with milliQ water.
Before each compression isotherm, the trough was ﬁlled with
acetate buffer 25mM at pH 5, the temperature was stabilised at
20 ◦C and after compression the surface was cleaned by suction.
The cleanliness of the system was checked with a blank.
The samples were dissolved in a mixture of CHCl3/CH3OH (v/v;
2/1) at a concentration between 0.5 and 1mM except for M1 for
which the concentration was 10mM.
Aprecise volume (varying between10 and100L) of the sample
wasdepositeddropbydropat the surfaceof theaqueousphasewith
a Hamilton syringe (Bonaduz AG, Switzerland).
After a waiting time of 15min allowing for solvent evapora-
tion and dispersion of the molecules at the surface, the ﬁlm was
compressed with the mobile barriers at a speed of 10mm/min cor-
responding to a reduction of the surface of 15 cm2/min. During the
compression the surface pressure was recorded. At least three rep-
etitions were done for each isotherm.
2.5. Study of the penetration of M1 and its bis-derivatives into a
membrane model
A monolayer of dipalmitoylphoshatidylcholine (DPPC) was cho-
sen as a membrane model and the experiments were carried out
with the Langmuir ﬁlm balance used for the surface pressure mea-
surements. The experimental set up was as described above except
that the trough used was smaller (205×75×5mm) with no well.
The sub-phase was prepared in the same manner as for the com-
pression isotherms.
The samples were dissolved in dimethylsulfoxide (DMSO) at a
concentration chosen such that after injection of 40L in the 75mL
of sub-phase the concentrationof themolecule in the latter reached
10M.
A solution of DPPC at 1mM was prepared in a CHCl3/CH3OH
mixture (v/v; 2/1). It was deposited drop by drop at the surface of
the sub-phase. The volume of DPPC depositedwas chosen such that
the area of themonolayer at the initial surface pressure (i) reached
approximately 55 cm2. After 15min, the ﬁlm was compressed until
attaining the desired i. The ﬁlm was then stabilised at a deﬁned
initial value until the change in the area was less than 0.10 cm2/min
and this during a minimum time of 15min.
The sample was then injected into the sub-phase with a Hamil-
ton syringe and the surface pressure was monitored until an
equilibrium state was reached.were injected in the sub-phase showed no surface pressure varia-
tion during at least 24h.
Experiments studying the adsorption of the molecules at the
buffer/air interface were identical to those of the penetration study
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. Results and discussion
.1. Impact of the modiﬁcation of M1’s structure on the surface
ension of its aqueous solutions
The inﬂuence on the surface properties of the M1 factor,
f increasing either M1’s hydrophobicity (esters), hydrophilicity
oximes) or both of these properties simultaneously (bis-
erivatives) was evaluated. The surface tension () of M1 solutions
nd its derivatives was determined using the drop volume ten-
iometer (TVT) in the dynamic mode.
The graph (a), Fig. 2, shows the evolution of dyn ∞ of solutions
f M1 at different concentrations. M1 decreases the surface tension
lightly. The higher the concentration the greater the decrease. The
urve shows no break and therefore no critical micellar concentra-
ion could be determined for the range of concentrations studied
hich was limited by the poor solubility of M1. Furthermore the
urves dyn obtained as function of time (results not shown) did
ot indicate any tendency of M1 to migrate towards the interface.
he value of dyn obtained after approximately 10min was very
lose to that reached after less than 10 s. Thus the results sug-
est that M1 has no or only slight surface-active characteristics
nd therefore behaves like any other organic molecule in solution
n water. This is consistent with the fact that no clear separation
etween a hydrophilic and a hydrophobic region can be predicted
y the planar formula of the antibiotic. However a certain degree of
mphiphilicity could have been expected. NMR studies (ROESY and
OESY) of M1 have shown that the antibiotic adopts different con-
ormations in various solvents. InCDCl3,which canbe considered as
model system for an hydrophobic environment, the hydrophilic
roups are oriented towards the interior of the molecule. On the
ontrary, in CD3OD, the hydrophilic groups are pointed outwards
nd the more hydrophobic groups are oriented inwards [12,13].
hese data suggests that M1 could adopt an optimal 3D structure
ig. 2. Evolution of the dynamic surface tension (dyn ∞) of solutions in milliQ water of M
heir concentrations. The dynamic surface tensions (dyn) obtained were extrapolated to
f the inverse of the square root of time (t−1/2).iointerfaces 69 (2009) 268–275 271
at a hydrophilic/hydrophobic interface. However, in view of the
results obtained in the present study, this conformational ﬂexibility
does not seem sufﬁcient to render M1 clearly amphiphilic and thus
surface-active. This ﬂexibility may well contribute to enhance the
surface activity of its derivatives.
The esters of M1 with fatty acids (M1C8, M1C12 and M1C14),
were scarcely soluble in water. At saturation of the solutions, the
dyn reached was around 70mN/m. Their effect on water’s surface
tension can thus be considered as negligible. They are either not
sufﬁciently amphiphilic or their concentrationsarenothighenough
to have a signiﬁcant inﬂuence on the  .
The graph (b), (c) and (d) of Fig. 2 show the evolution of the
dyn ∞ of the oximes of M1 with polar amino acids (M1AOASer,
M1AOALys and M1AOAAsp), as a function of their concentrations.
As for M1, the surface tension decreases as the concentration of the
derivatives increases but no CMC could be determined in the range
of concentrations tested. The results obtained with M1AOASer are
similar to those obtained with M1. The effects of M1AOALys and of
M1AOAAsp on the surface tension are slightly less than that of M1.
For example, the dyn ∞ of a 500M solution of M1AOALys (I1) is
approximately of 65mN/m compared to 60mN/m for M1. The iso-
mery of the oxime link does not affect the property studied here
(data not shown).
These initial results show that the modiﬁcation of only one
characteristic of M1, its hydrophobicity or its hydrophilicity, is not
sufﬁcient to render M1 surface-active. To confer a clear amphiphile
character to M1, it is necessary to modulate both characteristics.
Increasing its hydrophilicity is important to increase its water sol-
ubility and enhancing its hydrophobicity is also necessary in order
that the molecules do not tend to stay in the bulk of the solution
but migrate towards the interface.
The surface tension evolution of M1C8AOALys (mixture of I1
and I2) solutions as a function of time is shown for different con-
centrations in Fig. 3. Their surface tension decreases with time
1 (a) and its oximes with serine (b), lysine (c) and aspartic acid (d) in function of
an inﬁnite time (dyn ∞) by linear regression of the curves of the dyn as a function















































more energy is necessary for that passage.
The surface tension reached is lower for the longer chain deriva-
tives. This could be due to an increase in the attractive hydrophobic
interactions between the alkyl chains of the molecules whilst theig. 3. Graph of  = f(t) recorded by TVT in dynamicmode forM1C8AOALys (mixture
f I1 and I2) in milliQ water at different concentrations: () 21M; (♦) 35M; ()
2M; (©) 66M; (–) 132M.
hich indicates a tendency of the molecules to migrate towards
he air/water interface. Similar results were obtained for all the
is-derivatives of M1 synthesised. These derivatives thus behave
learly as surfactant molecules. The higher the concentration, the
aster the decrease. For the lowest concentration of M1C8AOALys,
he ﬁrst three regions characteristic of surfactant adsorption at an
ir/water interface are observed: the induction, the rapid fall and
eso-equilibrium regions [14]. For the two intermediary concen-
rations, the induction zone is not visible and for the two highest
oncentrations, only the meso-equilibrium region can be seen. The
raph also illustrates that the higher the concentration, the lower
he surface tension reached at the end of the measurement. This is
he case for all surfactants at concentrations below their CMC.
As the bis-derivatives show a clear surfactant character, a more
etailed study of their properties has been carried out and is pre-
ented below.
.2. Study of the relationship between the structure of the
is-derivatives and their surface properties
The inﬂuence of both the chain length (8, 12 or 14 carbon atoms)
nd the nature of the amino acid (Lys or Asp) of the bis-derivatives
n three categories of properties has been studied: the surface ten-
ion timedependenceof their solutions, the compression isotherms
f theirmonolayers at an air/water interface andﬁnally their capac-
ty to penetrate into a membrane model. The two ﬁrst categories of
roperties studied are important to better comprehend the fun-
amental surface properties of the derivatives and to link them to
heir structure. The third type of properties studied is a simple and
apid method to predict if the derivatives may have some inter-
sting biological activities. Indeed, the active site for M1 is at the
ibosomes of the bacteria. However, to be active, the antibioticmust
o through the outer layers of the cell. As a ﬁrst approach, it seemed
nteresting to investigate if the modiﬁcation of the hydrophobicity
nd hydrophilicity of M1 achieved in this work has an inﬂuence
n its capacity to interact with biological membranes. A monolayer
f dipalmitoyl phosphatidylcholine, a frequently applied model in
he literature [15–18], was used. Such a model allows easy con-
rol of its density by adjustment of its surface pressure and of the
xperimental conditions (pH and composition of the sub-phase,
emperature) [19,20]. The molecule was injected in the sub-phase
nder the monolayer of DPPC which was compressed at a given
urface pressure beforehand. The evolution of  was then followed
n function of the time elapsed after the injection. It is generally
onsidered that an increase of  indicates a penetration of the
olecule in the monolayer. The surface pressure increase reached
t the equilibrium as a function of the initial surface pressure of theFig. 4. Graph of the increase of surface pressure reached at equilibrium
( =eq − i) after injection of M1C12AOAAsp (I1) as function of the initial surface
pressure of the DPPC monolayer (i).
DPPCmonolayer allows thedeterminationof theexclusionpressure
(exclusion) of the compoundunderstudy.exclusion corresponding to
the intersection of the regression line with the abscissa represents
the surface pressure of the lipid monolayer at which the molecule
injected in the sub-phase can no longer penetrate in the monolayer
[19,21]. The Fig. 4 shows as an example the graph established for
the determination of the exclusion pressure of the bis-derivative
M1C12AOAAsp (I1).
3.2.1. Inﬂuence of the chain length of the fatty acid (8, 12 or 14)
The inﬂuence of the bis-derivatives chain length on the surface
tension time dependence of their solutions was studied using the
drop volume tensiometer. Fig. 5 illustrates the results obtained for
the bis-derivatives with lysine and a chain length of 8 and 12 car-
bon atoms at a low and high concentration. Similar results were
obtained for thosewith aspartic acid. For a given amino acid, at sim-
ilar concentrations, the longer the chain length of the bis-derivative
the slower its adsorptionkinetic at the interface. As itwas explained
by Razaﬁndralambo et al. [22] with surfactins, this could be due to
the fact that during the adsorption of the surfactant at the interface,
the alkyl chain of the adsorbing molecules must pass through the
layer of the molecules already adsorbed. The longer the chain, theFig. 5. Effect of the chain lengthof bis-derivativeson the surface tension timedepen-
dence of their solutions: example of the bis-derivatives with lysine: M1C8AOALys
(mixture of I1 and I2): () 35M and () 107M in milliQ water, M1C12AOALys
(mixture of I1 and I2): () 49M and () 120M in milliQ water.














































Fig. 7. Evolution of the surface pressure of a DPPC monolayer at the interfaceig. 6. Compression isotherms of the bis-derivatives M1C12AOALys (I1) (--) and
1C14AOAAsp (I1) (-). The compression isotherms of the other bis-derivatives have
similar form and for the sake of clarity they are not shown.
lectrostatic repulsion forces remained unchanged. This allows a
ore compact organisation at the interface and thus a higher
urface concentration which is directly linked to surface tension.
imilar tendencies have been frequently reported in the literature
22–24].
The monolayer properties of M1 and its bis-derivatives at an
ir–aqueous medium interface were studied using the Langmuir
rough technique. For M1, no stable monolayer was formed and
o compression isotherms could be observed under the exper-
mental conditions used. For the bis-derivatives, compression
sotherms have been recorded. Fig. 6 shows the compression
sotherms obtained for M1C12AOALys (I1) and M1C14AOAAsp (I1).
he isotherms of all the bis-derivatives have a similar shape and for
he sake of clarity the other isotherms are not shown. Two param-
ters were used to characterize the compression isotherms: the
imiting area (A0) and the collapse pressure (collapse). A0 is the
rea at which the surface pressure () begins to increase and dif-
ers from zero. It indicates that the molecules are close enough to
egin to interact. collapse is the highest pressure the ﬁlm can reach.
f the area is still further decreased the monolayer collapses and
he molecules go into the solution or rearrange into multilayers.
he characteristic parameters obtained for all the bis-derivatives
re compiled in Table 1.
For a given amino acid, the results show no inﬂuence of the
hain length of the fatty acid on the A0 or the collapse. The results
btained also showno signiﬁcant effect of the isomery of the oxime
ink.
Fig. 7 shows the evolution of the surface pressure of amonolayer
f DPPC initially compressed to a value of 26.5mN/m in function of
he time elapsed since the injection of M1C12AOALys (I1) in the
ub-phase (ﬁnal concentration of derivative of 10M). The pres-
ure remains stable during the ﬁrst 2h and then increases steadily
able 1
haracteristic parameters (average of three repetitions) of the compression
sotherms of M1’s bis-derivatives at the interface air/acetate buffer 25mM at pH
.
is-Derivative A0 (Å2/molecule) collapse (mN/m)
1C12AOALys (I1) 100.9 ± 4.2 41.1 ± 0.4
1C12AOALys (I2) 106.2 ± 0.7 40.6 ± 0.2
1C14AOALys (I1) 108.6 ± 3.6 41.5 ± 0.4
1C14AOALys (I2) 102.8 ± 0.9 42.1 ± 0.2
1C12AOAAsp (I1) 122.6 ± 4.1 39.7 ± 0.4
1C12AOAAsp (I2) 120.3 ± 0.9 38.4 ± 0.2
1C14AOAAsp (I1) 118.0 ± 3.6 40.5 ± 0.3
1C14AOAAsp (I2) 124.9 ± 1.1 40.4 ± 0.1air/acetate buffer 25mM at pH5 initially compressed at 26.5mN/m as a function
of the time elapsed after the injection in the buffer sub-phase of 40L of a DMSO
solution of M1C12AOALys (I1) (10M ﬁnal concentration in the sub-phase).
during more or less 5h to approximately 39mN/m. This value then
remains stable for 10h at least. This shows that the derivative is
able to penetrate into theDPPCmonolayer and that once in the lipid
environment remains stable andno rearrangement occurs thatmay
change the surface pressure. The kinetic of penetration of the bis-
derivatives into DPPC monolayers is very slow compared to other
bioactive amphiphile such as, for example, surfactin [18], colistin
[25] and fengycin [26]. This could be due to a reorganisation of the
molecules during their penetration or to the fact that a high energy
barrier must be overcome.
The experiments have shown that all the bis-derivatives syn-
thesised are able to penetrate a DPPC monolayer as can M1 to
a limited extent. The exclusion pressure of M1 and of the bis-
derivativesweredetermined. Table 2details the results obtained for
the bis-derivatives with aspartic acid. Their adsorption equilibrium
pressures at a clean interface (without DPPC) are also presented.
They are lower than their exclusion pressures. This suggests that
an interaction with DPPC occurs. This interaction maintains the
molecules in the monolayer even at surface pressure higher than
those attained after simple adsorption at the interface. If there
was no interaction, the derivatives would ﬁll the empty spaces
in the DPPC monolayer only until reaching their adsorption equi-
librium pressure [16,27]. Furthermore, increasing the chain length
enhances the capacity of penetration into theDPPCmonolayer. This
is also conﬁrmed by the fact that the exclusion pressure of M1
(exclusion = 20mN/m) is smaller than those of all the derivatives
studied. The same tendency was shown with the bis-derivatives
with lysine. The results obtained in this study conﬁrm that the
increase of the hydrophobic forces is in favour of the penetration
into lipidic monolayers [18,27].
3.2.2. Inﬂuence of the amino acid (Lys or Asp)
Fig. 8 shows the surface tension time dependence of solutions of
bis-derivativeswith the samechain length (eight carbonatoms)and
either lysine or aspartic acid as the polar part. As for the molecules
with 12 carbon atoms, no signiﬁcant inﬂuence of the nature of the
amino acid on the kinetics of the adsorption at the air/aqueous
interface clearly appears.
However, the results obtained have shown that the bis-
derivativeswith lysine reach lower surface tensions than thosewith
aspartic acid. This could be due to the existence of a higher adsorp-
tion barrier in the case of the Asp derivatives due to repulsion forces
between the adsorbed molecules. Indeed at pH 5, Asp residue is
predominantly charged twice negatively while Lys is zwiterrionic.
Apparently the ions of the buffer cannot totally compensate the
charges.
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Table 2
Effect of the chain length of M1’s bis-derivatives on their exclusion pressure in a DPPC monolayer and on their adsorption pressure at the interface air/acetate buffer 25mM
at pH 5 (concentration of the bis-derivatives: 10M): an example with the bis-derivatives with aspartic acid. (N.D.: not determined).
bis-Derivative M1C8AOAAsp (I1 and I2) M1C12AOA
exclusion (mN/m) 29 45
adsorption (mN/m) 17 34
Fig. 8. Effect of the nature of the amino acid of M1’s bis-derivatives on the surface
tension time dependence of their solutions: an example of the bis-derivativeswith a
chain length of eight carbon atoms: M1C8AOALys (mixture of I1 and I2): () 69M
in acetate buffer 25mM at pH 5, M1C8AOAAsp (mixture of I1 and I2): (©) 62M in
acetate buffer 25mM at pH 5.
Table 3
Effect of the nature of the amino acid of M1’s bis-derivatives on their exclusion
pressure in a DPPC monolayer and on their adsorption pressure at the interface
air/acetate buffer 25mM at pH 5 (concentration of the bis-derivatives: 10M): an




























tis-Derivative M1C8AOALys (I1 and I2) M1C8AOAAsp (I1 and I2)
exclusion (mN/m) 36 29
adsorption (mN/m) 27 17
The results shown in Table 1 for the compression isotherms of
hebis-derivatives indicate that, for a given chain length, thederiva-
ives with aspartic acid are more expanded at the beginning of the
ompression than those with lysine. This could be due to higher
lectrostatic repulsion forces occurring between the twice nega-
ively charged Asp derivatives than between the zwiterrionic Lys
ased molecules. Table 3 shows that the adsorption and exclusion
ressure of the bis-derivativewith lysine are higher than thosewith
spartic acid. Indeed, the molecules with aspartic acid are more
xtended (repulsion), their density at the surface is lower and thus
he adsorption pressure reached is lower than in the case of the
witerrionic lysine derivatives. In presence ofDPPCwhich is zwiter-
ionic, the negative charges of Asp are not completely hidden and
he exclusion pressures for the Asp derivatives are lower than those
ith lysine.
. Conclusions and perspectives
In conclusion, this study has shown that virginiamycin M1 is
ot surface-active. It is necessary to enhance both its hydrophobic-
ty and hydrophilicity to render it surface-active as was shown by
he properties of the bis-derivatives. A structure/function relation-
hip studyof thebis-derivativeswasundertaken. Thecomparisonof
he properties of the bis-derivatives having a given amino acid and
ncreasing chain length has shown that enhancing the hydropho-
icity of the molecules leads to a slower adsorption kinetic, lower
urface tensions, higher stability of themonolayers formedandbet-
er capacity to penetrate a membrane model. The comparison of
he properties of the molecules having the same chain length but aAsp (I1) M1C12AOAAsp (I2) M1C14AOAAsp (I2)
44 50
N.D. 40
different amino acid has shown that increase of the repulsive elec-
trostatic forces lead to higher surface tensions, a greater molecular
area at the interface and lower penetration into amembranemodel.
The study of the penetration of M1 and the bis-derivatives in
a DPPC monolayer has shown that all these molecules, except
M1 and M1C8AOAAsp, have an exclusion pressure greater than
30–35mN/m which is generally considered as the value of the
lateral pressure that reigns in biological membranes [28]. This sug-
gests that these molecules, under the conditions used in this study,
can potentially insert into biological membranes in vivo. In the
future it would be very interesting to verify this hypothesis with
more complex membrane models such as bilayers or liposomes but
also in vitro by studying the minimum inhibitory concentrations
of M1 and the bis-derivatives towards bacteria. It would be inter-
esting to know if the new surface properties of the bis-derivatives
allow them to penetrate the outer membrane of the Gram negative
bacteria.
It will be also important to test the activity of these new deriva-
tives towards resistant bacteria as they may be as effective as
dalfopristin.
Some studies have shown that M1 and some of its derivatives
(esters and carbamates) were antagonists of regulation peptides
such as gastrin and cholecystokinin that are found in the gastroin-
testinal tissues and in the central nervous system. Such compounds
could beuseful to treat numerous illnesses such as ulcers, Zollinger-
Ellison syndrome and different cancers [29,30]. It would be very
interesting to test the new derivatives studied here for antagonist
activity towards these regulatory peptides.
This work has shown that by systematically studying the impact
of modifying the hydrophobicity or/and the hydrophilicity of a
compoundon its surfaceproperties it is possible toproduce surface-
active derivatives from a non surfactant molecule. This strategy
could be used with many other active agents and may lead to the
obtention of new molecules combining the initial properties of the
agent to new ones that may enlarge its ﬁeld of applications. A pos-
sibility for example could be in the pharmaceutical or cosmetic
ﬁeldwhere the combination of formulation properties to biological
activities is particularly looked for.
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